quinoxalines has been researched along with Angioma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, X; Liu, N; Lu, W; Ma, Q; Qu, X; Zhu, C | 1 |
| Chu, MB; Searcy, G; Siegfried, E | 1 |
2 other study(ies) available for quinoxalines and Angioma
| Article | Year |
|---|---|
Silencing long non-coding RNA MEG8 inhibits the proliferation and induces the ferroptosis of hemangioma endothelial cells by regulating miR-497-5p/NOTCH2 axis.
Topics: Amino Acid Transport System y+; Apoptosis Regulatory Proteins; Base Sequence; Cell Proliferation; Cyclohexylamines; Down-Regulation; Endothelial Cells; Ferroptosis; Gene Silencing; Hemangioma; Humans; MicroRNAs; Mitochondrial Proteins; Phenylenediamines; Phospholipid Hydroperoxide Glutathione Peroxidase; Quinoxalines; Receptor, Notch2; RNA, Long Noncoding; RNA, Small Interfering; Spiro Compounds | 2021 |
Efficacy of topical brimonidine-timolol for haemangioma of infancy and perils of off-label prescribing.
Topics: Brimonidine Tartrate, Timolol Maleate Drug Combination; Drug Combinations; Female; Hemangioma; Humans; Infant; Male; Off-Label Use; Quinoxalines; Timolol | 2013 |